The Technical Analyst
Select Language :
ALX Oncology Holdings [ALXO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

ALX Oncology Holdings Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

ALX Oncology Holdings is listed at the  Exchange

-2.28% $11.15

America/New_York / 28 mar 2024 @ 16:00


ALX Oncology Holdings: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 559.20 mill
EPS: -3.74
P/E: -2.98
Earnings Date: May 08, 2024
SharesOutstanding: 50.15 mill
Avg Daily Volume: 0.367 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.98 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.51x
Company: PE -2.98 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.121
(-98.91%) $-11.03
Date: 2024-03-29
Expected Trading Range (DAY)

$ 9.98 - 12.36

( +/- 10.68%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-14 Lettmann Jason Buy 4 400 Common Stock
2024-02-14 Pinto Shelly Buy 15 000 Common Stock
2024-02-14 Pinto Shelly Buy 35 000 Employee Stock Option (right to buy)
2024-02-14 Garcia Peter S Buy 25 000 Common Stock
2024-02-14 Garcia Peter S Buy 80 000 Employee Stock Option (right to buy)
INSIDER POWER
95.48
Last 97 transactions
Buy: 3 568 851 | Sell: 526 117

Forecast: 16:00 - $11.18

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $11.18
Forecast 2: 16:00 - $11.18
Forecast 3: 16:00 - $11.18
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $11.15 (-2.28% )
Volume 1.052 mill
Avg. Vol. 0.367 mill
% of Avg. Vol 286.63 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for ALX Oncology Holdings Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for ALX Oncology Holdings Inc.

RSI

Intraday RSI14 chart for ALX Oncology Holdings Inc.

Last 10 Buy & Sell Signals For ALXO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$13.99N/AActive
Profile picture for
            ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell carcinoma, human epidermal growth factor receptor 2 (HER2) positive gastric/gastroesophageal junction carcinoma, HER2-expressing breast cancer, and other solid tumors. The company's pre-clinical products include ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer. ALX Oncology Holdings Inc. has a collaboration agreement with Merck for a Phase 2 trial evaluating ALX148 in combination with pembrolizumab with and without chemotherapy in patients with head and neck cancer; Zymeworks on a Phase 1 trial evaluating ALX148 with the HER2-targeting bispecific antibody zanidatamab in patients with HER2-expressing breast cancer and other solid tumors; and Tallac Therapeutics for the development, manufacturing and commercialization of a novel class of cancer immunotherapeutics. It also has a license agreement with Selexis SA and Crystal Bioscience, Inc. The company was founded in 2015 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
SUPERUSDMar 29 - 09:34$1.359
UQCUSDMar 29 - 06:54$7.20
BNBUSDMar 29 - 09:31$615.19
TIMEUSDMar 29 - 09:3232.37
AGLDUSDMar 29 - 09:301.650
MINAUSDMar 29 - 09:29$1.238
CBKUSDMar 29 - 09:281.087
METAMar 28 - 16:00$485.58
MSTRMar 28 - 16:00$1 704.56
STORJUSDMar 29 - 09:26$0.817

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.